This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yu, G. V. Articles by Hudson, J. R. Search for Related Content PubMed PubMed Citation Articles by Yu, G. V. Articles by Hudson, J. R.

Evaluation and Treatment of Stage 0 Charcot’s Neuroarthropathy of the Foot and Ankle

Gerard V. Yu, DPM^* and Justin R. Hudson, DPM

^* Diplomate, American Board of Podiatric Surgery; Fellow, American College of Foot and Ankle Surgeons; Director of Podiatric Medical Education and Residency Training, St Vincent Charity Hospital, Cleveland, OH; Faculty Member, The Podiatry Institute, Tucker, GA. Mailing address: 23823 Lorain Rd, Ste 280, North Olmstead, OH 44070.
Submitted during third-year residency, St Vincent Charity Hospital, Cleveland, OH.

Abstract

Charcot’s neuroarthropathy is a relatively common disease in patients with diabetic neuropathy. If unrecognized or left untreated, Charcot’s neuroarthropathy can result in a severely misshapen and unstable foot and ankle. Ulceration, soft-tissue infection, and osteomyelitis frequently ensue, and partial or complete amputation of the foot is not uncommon. A high index of suspicion and proper interpretation of clinical and diagnostic findings are essential to establish a timely and accurate diagnosis and to institute appropriate treatment. The pathogenesis of neuroarthropathy is reviewed and diagnosis and treatment of the stage 0 diabetic Charcot foot are presented. (J Am Podiatr Med Assoc 92(4): 210-220, 2002)

This article has been cited by other articles:

				M. S. Judge Infection and Neuroarthropathy: The Utility of C-reactive Protein as a Screening Tool in the Charcot Foot J Am Podiatr Med Assoc, January 1, 2008; 98(1): 1 - 6. [Abstract] [Full Text] [PDF]